The U.S. Food and Drug Administration (FDA) recently announced the approval of Besremi (generic name: ropeginterferon alfa-2b-njft) for the treatment of true erythrocytosis (Polycythemia Vera, PV). This decision marks Besremi as the first FDA-approved interferon…
UCB has recently announced that its innovative therapy, Bimzelx (generic name: bimekizumab-bkzx), has received approval from the U.S. Food and Drug Administration (FDA) for multiple new indications, solidifying its role in treating various immune-mediated inflammatory…
Lachen, Switzerland – Octapharma has announced that the final results from the NuProtect study on the immunogenicity of Nuwiq® in previously untreated patients (PUPs) with severe hemophilia A have been published in the medical journal…
In the world of immunology and asthma management, Benralizumab Injection has emerged as a game-changer for patients struggling with severe eosinophilic asthma and eosinophilic granulomatosis with polyangiitis (EGPA). This monoclonal antibody, developed by AstraZeneca in…
The trade name of emapalumab lzsg is Gamifant, which is an anti interferon gamma (IFN gamma) antibody drug used to treat hemophagocytic lymphohistiocytosis (HLH). As a promising new option for patients with this rare and…
Introduction Lung cancer is one of the most common and serious types of cancer, but thanks to modern medicine, there have been significant advances in new medication for lung cancer over the past few years.…
In the field of cancer treatment, targeted therapies and antibody-drug conjugates (ADCs) are emerging as breakthrough treatment options. As one of the most important advances in this area, Padcev (generic name: Enfortumab Vedotin) has recently…
Recently, the U.S. Food and Drug Administration (FDA) officially approved Carvykti (Ciltacabtagene Autoleucel, or Cilta-cel), a CAR-T cell therapy jointly developed by Johnson & Johnson and Legend Biotech, for the treatment of adult patients with…
Recently, the U.S. Food and Drug Administration (FDA) officially approved Turoctocog Alfa Pegol (brand name: Esperoct®), a new long-acting Factor VIII drug developed by Novo Nordisk, for the treatment of Hemophilia A. This groundbreaking drug…
Mavacamten Capsules, a revolutionary drug for treating obstructive hypertrophic cardiomyopathy (HCM), is gaining attention due to its ability to reduce left ventricular outflow tract (LVOT) obstruction. In this article, DengYue will explore its mechanism of…
February 25, 2025 – In an exciting advancement in immunotherapy, the combination of Iparomlimab and Tuvonralimab injection is demonstrating significant efficacy in the treatment of multiple cancers and autoimmune diseases, according to recent clinical trial…
Janagliflozin, also known as Ganagliflozin Proline Tablets, marketed under the brand name HuiYouJing, is an innovative drug that has gained attention for its effectiveness in managing type 2 diabetes. As a member of the SGLT2…
